NIH Consortium to Study Biomarkers for Dementia

• Autores: Jennifer Abbasí
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 317, Nº. 16, 2017, págs. 1614-1614
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • A new National Institutes of Health (NIH)–funded consortium will work to identify and validate trial-ready biomarkers for small vessel diseases in the brain that contribute to cognitive impairment and dementia. Seven participating research sites across the country will develop their own imaging and fluid-based biomarkers and scale them up across the consortium, explained neurologist Steven M. Greenberg, MD, PhD, who will lead the project’s coordinating center at Massachusetts General Hospital